← Leaderboards
Edward Balish
University Of Wisconsin Madison
$1,958,085
Attributed
$1,958,085
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $228.3K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$1,958,085 · 5
By mechanism
R01$1,217,200 · 1
P20$740,885 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Dale E Bjorling$12,288,243
- Anne E Griep$8,692,152
- Charles J Czuprynski$5,542,281
- Glen S Kwon$5,558,269
- David R Andes$20,347,146
Others in their field
Top investigators on “Oral Pharyngeal Disorder”
- David Heimbrook · Leidos Biomedical Research, Inc.$24,292,334
- Larry Arthur$13,576,120
- David A Wellman · Brigham And Women'S Hospital$7,961,936
- Jerilyn A Logemann · Northwestern University$6,703,504
- Houri K Vorperian · University Of Wisconsin Madison$4,929,202
- Marc Moss · Emory University$4,181,577
Research focus
Oral Pharyngeal DisorderGerm Free ConditionCytokineDevelopmental ImmunologyPhagocytesImmunotherapyEsophagus DisorderCandidiasisLaboratory MouseThymusT LymphocyteCellular ImmunityMucosal ImmunityNonhuman Therapy EvaluationPathologyResearch PersonnelResourcesSourceTechnologyTransgenic OrganismsUnited States National Institutes Of HealthAnimal FacilityVeterinary MedicineAnimals
Grant awards (10)
SC COBRE: ANIMAL PATHOBIOLOGY CORE$131,772
P20 · FY2007 · RR · contact PI
SC COBRE: ANIMAL PATHOBIOLOGY CORE$114,699
P20 · FY2006 · RR · contact PI
SC COBRE: ANIMAL PATHOBIOLOGY CORE$228,314
P20 · FY2005 · RR
CORE--ANIMAL PATHOBIOLOGY$266,100
P20 · FY2004 · RR
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$243,100
R01 · FY2004 · DE
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$243,100
R01 · FY2003 · DE
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$243,100
R01 · FY2002 · DE
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$243,100
R01 · FY2001 · DE
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$240,100
R01 · FY2000 · DE
LETHAL OROESOPHAGEAL CANDIDIASIS: IMMUNOTHERAPY$4,700
R01 · FY2000 · DE